companydata.dkcompanydata.dk

Nykode Therapeutics Denmark A/S: Financial statements 2023

CVR: 42038660

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

Nykode Therapeutics Denmark A/S (CVR 42038660) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 52,927,648 and a net result of DKK 2,484,505 compared with DKK 1,895,426 the year before. That is an increase of 37% compared with the year before. Equity in the 2023 report amounted to DKK 5,358,013. The solvency ratio was 26.1%. The company had 31 employees in the financial year.

Gross Profit
DKK 52,927,648
Profit/Loss
DKK 2,484,505
Equity
DKK 5,358,013
Total Assets
DKK 20,504,300
Employees
31

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-52.9M2.5M5.4M31
2022-38.6M1.9M2.9M23
2021-10.6M578K978K7

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Nykode Therapeutics Denmark A/S: The 2022 annual report is outJun 28, 2023

Nykode Therapeutics Denmark A/S has published its annual report for 2022. Gross profit came to DKK 38,639,042, and the net result was DKK 1,895,426.

About Nykode Therapeutics Denmark A/S

Nykode Therapeutics Denmark A/S is a Danish company of the type Aktieselskab based in Kongens Lyngby, founded in 2021. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named Vaccibody Denmark A/S. The management consists of Michael Thyrring Engsig. The board consists of Louise Stubbe (chair), Harald Gurvin and Michael Thyrring Engsig. The company is owned by Nykode Therapeutics ASA. The company has 11 employees (2026). In 2025, the company reported a gross profit of DKK 31,839,001 and a net result of DKK 1,347,127 compared with DKK 156,959 the year before. Equity in the 2025 report amounted to DKK 6,862,099.

Source: annual report 2025, Danish Business Authority

Other financial years